Alembic Pharma Gets USFDA Approval for Hereditary Angioedema Injection
June 17, 2024 13:29
Alembic Pharmaceuticals receives USFDA approval for its generic Icatibant injection, a treatment for acute attacks of hereditary angioedema (HAE) in adults. This is the company's first peptide...